Jet nebulizers use a compressor to aerosolize liquid medication, which is then delivered
via a face mask or mouthpiece.8
Jet nebulizers form droplets by using a compressor to deliver a pressurized jet
stream of air down a narrow tube and through a narrow opening.8 The result is a drop
in pressure that creates a vacuum effect (Venturi effect), forcing the liquid drug
to come up from the reservoir.8,9 Small droplets of liquid created in this manner are
propelled out of the device by the jet stream.8
IMPORTANT SAFETY INFORMATION ABOUT PULMICORT
PULMICORT RESPULES is not a bronchodilator and is NOT indicated for the relief of
Particular care is needed for patients who are transferred from systemically active
corticosteroids to PULMICORT RESPULES, because deaths due to adrenal insufficiency
have occurred in asthmatic patients during and after transfer from systemic corticosteroids
to less systemically available inhaled corticosteroids.
It is possible that systemic corticosteroid effects such as hypercorticism, reduced
bone mineral density, and adrenal suppression may appear in a small number of patients,
particularly at higher doses.
Patients taking immunosuppressant doses of corticosteroids should avoid exposure
to infections such as chicken pox and measles.
Inhaled corticosteroids may cause a reduction in growth velocity. The long-term
effect on final adult height is unknown.
Hypersensitivity reactions, including anaphylaxis, have been reported with budesonide.
As with other inhaled medications, paradoxical bronchospasm may occur with
In rare cases, patients on inhaled corticosteroids may present with systemic eosinophilic
conditions and clinical features consistent with Churg-Strauss Syndrome.
Adverse reactions that occurred at a rate of ≥ 3% are: respiratory infection, rhinitis, coughing, otitis media, viral infection, moniliasis, gastroenteritis, vomiting, diarrhea, abdominal pain, ear infection, epistaxis, conjunctivitis, and rash.
PULMICORT RESPULES (budesonide inhalation suspension) is indicated for the maintenance
treatment of asthma and as prophylactic therapy in children ages 12 months to 8 years.
for full Prescribing Information for PULMICORT RESPULES.
You are encouraged to report negative side effects of prescription
drugs to the FDA.
Visit www.FDA.gov/medwatch or call